Aimery de Gramont Selected Research

Oxaliplatin (Eloxatin)

1/2021	Microsatellite Instability in Patients With Stage III Colon Cancer Receiving Fluoropyrimidine With or Without Oxaliplatin: An ACCENT Pooled Analysis of 12 Adjuvant Trials.
1/2021	Sex and Adverse Events of Adjuvant Chemotherapy in Colon Cancer: An Analysis of 34 640 Patients in the ACCENT Database.
1/2021	Adverse event load, onset, and maximum grade: A novel method of reporting adverse events in cancer clinical trials.
1/2021	Benefit of Oxaliplatin in Stage III Colon Cancer According to IDEA Risk Groups: Findings from the ACCENT Database of 4934 Patients.
10/2020	Association of Bevacizumab Plus Oxaliplatin-Based Chemotherapy With Disease-Free Survival and Overall Survival in Patients With Stage II Colon Cancer: A Secondary Analysis of the AVANT Trial.
1/2019	Association of post-operative CEA with survival and oxaliplatin benefit in patients with stage II colon cancer: a post hoc analysis of the MOSAIC trial.
1/2018	Three Versus 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Patients With Stage III Colon Cancer: Disease-Free Survival Results From a Randomized, Open-Label, International Duration Evaluation of Adjuvant (IDEA) France, Phase III Trial.
2/2017	MABp1 as a novel antibody treatment for advanced colorectal cancer: a randomised, double-blind, placebo-controlled, phase 3 study.
3/2016	Impact of Patient Factors on Recurrence Risk and Time Dependency of Oxaliplatin Benefit in Patients With Colon Cancer: Analysis From Modern-Era Adjuvant Studies in the Adjuvant Colon Cancer End Points (ACCENT) Database.
3/2016	Chemoradiotherapy with FOLFOX plus cetuximab in locally advanced oesophageal cancer: The GERCOR phase II trial ERaFOX.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Aimery de Gramont Research Topics

Disease

57	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 04/2002
45	Colonic Neoplasms (Colon Cancer) 11/2021 - 08/2003
39	Neoplasms (Cancer) 01/2022 - 06/2003
10	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2003
6	Microsatellite Instability 01/2021 - 01/2004
5	Neutropenia 01/2021 - 01/2004
5	Nausea 01/2021 - 11/2003
4	Vomiting 01/2021 - 11/2003
3	Breast Neoplasms (Breast Cancer) 08/2021 - 01/2005
3	Leukopenia 01/2021 - 11/2003
3	Stomach Neoplasms (Stomach Cancer) 04/2015 - 04/2002
3	Carcinoma (Carcinomatosis) 12/2012 - 04/2002
3	Pancreatic Neoplasms (Pancreatic Cancer) 08/2006 - 04/2002
2	Triple Negative Breast Neoplasms 08/2021 - 03/2018
2	Diarrhea 01/2021 - 07/2011
2	Anemia 01/2021 - 01/2020
2	Rectal Neoplasms (Rectal Cancer) 11/2018 - 01/2018
2	Disease Progression 11/2015 - 05/2015
2	Sarcoma (Soft Tissue Sarcoma) 05/2015 - 03/2012
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2015 - 06/2012
2	Adenocarcinoma 04/2015 - 01/2007
2	Ovarian Neoplasms (Ovarian Cancer) 01/2005 - 11/2003
1	Thrombocytosis (Thrombocythemia) 09/2021
1	Stomatitis 01/2021
1	Thrombocytopenia (Thrombopenia) 01/2021
1	Liver Diseases (Liver Disease) 01/2018
1	Fatigue 02/2017
1	Weight Loss (Weight Reduction) 02/2017
1	Inflammation (Inflammations) 02/2017
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 09/2016
1	Cachexia 01/2016
1	Neoplasm Micrometastasis 11/2015
1	Exanthema (Rash) 11/2015
1	Asthenia 11/2015
1	Neuroblastoma 05/2015
1	Colitis 05/2015

Drug/Important Bio-Agent (IBA)

50	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021 - 04/2002
48	Fluorouracil (Carac)FDA LinkGeneric 07/2021 - 04/2002
33	Leucovorin (Folinic Acid)FDA Link 07/2021 - 04/2002
18	Irinotecan (Camptosar)FDA LinkGeneric 01/2021 - 04/2002
17	Bevacizumab (Avastin)FDA Link 10/2020 - 01/2005
13	Cetuximab (Erbitux)FDA Link 11/2018 - 07/2006
9	ErbB Receptors (EGF Receptor)IBA 01/2020 - 05/2005
9	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 02/2006
8	Sodium Glutamate (Accent)IBA 11/2021 - 10/2007
8	Monoclonal AntibodiesIBA 02/2018 - 01/2007
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 05/2010
7	Capecitabine (Xeloda)FDA Link 07/2021 - 12/2006
6	Pharmaceutical PreparationsIBA 01/2016 - 10/2003
5	Cisplatin (Platino)FDA LinkGeneric 05/2015 - 04/2002
4	Gemcitabine FDA Link 09/2016 - 04/2002
3	Folic Acid (Vitamin M)FDA LinkGeneric 07/2021 - 04/2002
3	Angiogenesis InhibitorsIBA 01/2019 - 12/2006
3	Tyrosine Kinase InhibitorsIBA 01/2018 - 07/2007
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 08/2021 - 03/2018
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 08/2021 - 03/2018
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2020 - 03/2012
2	Alkaline PhosphataseIBA 01/2020 - 02/2017
2	Carcinoembryonic AntigenIBA 01/2019 - 01/2003
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2018 - 11/2015
2	Epidermal Growth Factor (EGF)IBA 01/2018 - 06/2004
2	Immune Checkpoint InhibitorsIBA 01/2017 - 03/2016
2	PlatinumIBA 09/2016 - 12/2013
2	XELOXIBA 03/2016 - 12/2012
2	nintedanibIBA 07/2014 - 10/2011
2	DNA (Deoxyribonucleic Acid)IBA 01/2014 - 10/2011
2	Levamisole (Decaris)FDA Link 07/2007 - 06/2004
2	Pemetrexed (MTA)FDA Link 11/2004 - 04/2002
2	AnthracyclinesIBA 11/2003 - 04/2002
2	Hydroxyurea (Hydrea)FDA LinkGeneric 06/2003 - 01/2003
1	Circulating Tumor DNAIBA 10/2021
1	olaparibIBA 08/2021
1	selinexorIBA 08/2021
1	Drug CombinationsIBA 07/2021
1	trifluridine tipiracil drug combinationIBA 07/2021
1	tegafur-gimeracil-oteracilIBA 07/2021
1	Calcibiotic Root Canal SealerIBA 01/2020
1	E-SelectinIBA 01/2019
1	afliberceptIBA 09/2018
1	Histone Deacetylases (Histone Deacetylase)IBA 03/2018
1	AlbuminsIBA 01/2018
1	Hemoglobins (Hemoglobin)IBA 01/2018
1	LigandsIBA 01/2018
1	BilirubinIBA 01/2018
1	InterleukinsIBA 02/2017
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 02/2017
1	ribociclibIBA 01/2017
1	Mitogen-Activated Protein KinasesIBA 03/2016
1	Dihydrotachysterol (AT 10)IBA 12/2015
1	Docetaxel (Taxotere)FDA Link 05/2015
1	Trastuzumab (Herceptin)FDA Link 04/2015

Therapy/Procedure

46	Therapeutics 09/2021 - 08/2003
38	Drug Therapy (Chemotherapy) 07/2021 - 04/2002
23	Adjuvant Chemotherapy 01/2021 - 01/2004
2	Salvage Therapy 01/2022 - 03/2012
2	Radiotherapy 01/2022 - 03/2016
2	Duration of Therapy 10/2021 - 01/2018
2	Chemoradiotherapy 03/2016 - 01/2007
1	Hepatectomy 03/2015
1	Radiofrequency Ablation 03/2015